The rise of GLP-1 drugs like Ozempic and Mounjaro is not only altering consumer eating habits but also driving the growth of precision nutrition, which aims to tailor diets to individuals’ unique biological and metabolic profiles. This shift towards personalized nutrition, supported by advances in AI and an evolving understanding of metabolism, is set to revolutionize the food industry by creating highly customized food options that align with individual health goals.
This is an ainewsarticles.com news flash; the original news article can be found here: Read the Full Article…
